Martingale Asset Management L P Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $524,311 - $680,727	-4,763 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $289,316 - $430,740	-2,901 Reduced 37.85%	4,763 $656,000
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $361,395 - $507,854	3,656 Added 91.22%	7,664 $1.06 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $263,646 - $420,920	4,008 New	4,008 $389,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.